Page last updated: 2024-11-13

1,3-di-(4-amidinophenoxy)-2,2-bis-(4-amidinophenoxymethyl)propane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3-di-(4-amidinophenoxy)-2,2-bis-(4-amidinophenoxymethyl)propane: RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID44144524
MeSH IDM0161748

Synonyms (11)

Synonym
tapp-h
tetra-p-amidinophenoxy-neo-pentane
tetra-4-amidinophenoxyneopentane
4,4'-((2,2-bis((4-(aminoiminomethyl)phenoxy)methyl)-1,3-propanediyl)bis(oxy))bisbenzenecarboximidamide
1,3-di-(4-amidinophenoxy)-2,2-bis-(4-amidinophenoxymethyl)propane
1,3-bis(p-amidinophenoxy)-2,2-bis(p-amidinophenoxymethyl)propane
benzenecarboximidamide, 4,4'-(((2,2-bis((4-aminoiminomethyl)phenoxy)methyl)-1,3-propanediyl)bis(oxy))bis-
tapnp
82332-92-1
DTXSID401002617
4,4'-[(2-{[4-carbamimidoyl-2-(4-carbamimidoylphenoxy)phenoxy]methyl}propane-1,3-diyl)bis(oxy)]di(benzene-1-carboximidamide)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Despite these therapeutic effects, significant chronic toxicity of the compound was observed when administered at higher dosage (500-1000 micrograms)."( Antitumor activity of the proteinase inhibitor tetra-p-amidinophenoxyneopentane in a nude mouse model of human melanoma.
Barbieri, R; Bartolazzi, A; Gambari, R; Nastruzzi, C; Natali, PG,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (30.00)18.7374
1990's6 (60.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.82 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]